Leman Biotech Co., Ltd. (hereinafter referred to as "Leman Biotech"), a new biotech company specializing in cancer immunotherapy drug R&D, has completed a successful angel round of financing, raising $11 million. The round was led by Tiantu Capital, with support from 5Y Capital and XtalPi.